E Di Gennaro - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Scientific Reports|October 28, 2020

Transition from a uni- to a bimodal interfacial charge distribution in [Formula: see text]/[Formula: see text] upon coolingM Zwiebler, E Di Gennaro, J E Hamann-Borrero, et al.

Cell Death and Differentiation|April 18, 2003

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cellsM Caraglia, P Tagliaferri, M Marra, et al.

British Journal of Cancer|November 4, 2010

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseE Di Gennaro, G Piro, M I Chianese, et al.

Cell Death & Disease|October 26, 2013

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysF Bruzzese, B Pucci, M R Milone, et al.

Nature Materials|December 8, 2015

Tunable spin polarization and superconductivity in engineered oxide interfacesD Stornaiuolo, C Cantoni, G M De Luca, et al.

ESMO Open|January 5, 2023

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyC Cardone, A De Stefano, G Rosati, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Scientific Reports|October 28, 2020

Transition from a uni- to a bimodal interfacial charge distribution in [Formula: see text]/[Formula: see text] upon coolingM Zwiebler, E Di Gennaro, J E Hamann-Borrero, et al.

Cell Death and Differentiation|April 18, 2003

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cellsM Caraglia, P Tagliaferri, M Marra, et al.

British Journal of Cancer|November 4, 2010

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseE Di Gennaro, G Piro, M I Chianese, et al.

Cell Death & Disease|October 26, 2013

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysF Bruzzese, B Pucci, M R Milone, et al.

Nature Materials|December 8, 2015

Tunable spin polarization and superconductivity in engineered oxide interfacesD Stornaiuolo, C Cantoni, G M De Luca, et al.

ESMO Open|January 5, 2023

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyC Cardone, A De Stefano, G Rosati, et al.

Pageof 2